Clinical trials
Withdrawn Phase 1 Urinary Bladder Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2009 | 1 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2021 | 2 |
| 2022 | 2 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 13 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Brown University | 1 |
| Daniel George, MD | 1 |
| Eisai Inc. | 1 |
| Flame Biosciences | 1 |
| Guru P. Sonpavde | 1 |
| National Cancer Institute (NCI) | 1 |
| Pfizer | 1 |
| QuantumLeap Healthcare Collaborative | 1 |
| Tocagen Inc. | 1 |
| University of Pittsburgh | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urinary Bladder Neoplasms | 13 |
| Non-Muscle Invasive Bladder Neoplasms | 3 |
| Breast Neoplasms | 2 |
| Endometrial Neoplasms | 2 |
| Sarcoma | 2 |
| Acrocephalosyndactylia | 1 |
| Carcinoma in Situ | 1 |
| Colorectal Neoplasms | 1 |
| Neoplasm Metastasis | 1 |
| Ovarian Neoplasms | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.